Nucleus Network Ltd
14
1
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
60%
6 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19
Role: collaborator
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers
Role: collaborator
MMV533 Plasmodium Falciparum Volunteer Infection Study
Role: collaborator
A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533.
Role: collaborator
A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.
Role: collaborator
A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)
Role: collaborator
Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects
Role: collaborator
Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine
Role: collaborator
Controlled Human Infection for Vaccination Against Streptococcus Pyogenes
Role: collaborator
Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects
Role: collaborator
Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers
Role: collaborator
Phase 1 Study Accessing the Safety and Tolerability of CBP-307
Role: collaborator
Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers
Role: collaborator
The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes
Role: collaborator
All 14 trials loaded